Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.86B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
Mercado Libre
MELI
|
+$1.59B |
| 4 |
TSMC
TSM
|
+$1.34B |
| 5 |
Coupang
CPNG
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$2.61B |
| 2 |
EPAM Systems
EPAM
|
+$1.48B |
| 3 |
Twilio
TWLO
|
+$1.35B |
| 4 |
Apple
AAPL
|
+$1.24B |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.54% |
| 2 | Healthcare | 9.8% |
| 3 | Financials | 9.16% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PZC
4676
DELISTED
PIMCO California Municipal Income Fund III
PZC
| $1.29M | ﹤0.01% |
144,964
-10,386
| -7% | -$101K |
|
4677
Grupo Cibest SA
CIB
$22.8B
| $1.29M | ﹤0.01% |
30,342
-16,583
| -35% | -$598K |
|
|
VAPO
4678
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $1.29M | ﹤0.01% |
11,615
+1,681
| +17% | +$210K |
|
4679
MiMedx Group
MDXG
$622M
| $1.29M | ﹤0.01% |
273,957
+121,140
| +79% | +$592K |
|
4680
Boston Omaha
BOC
$421M
| $1.29M | ﹤0.01% |
50,819
-31,837
| -39% | -$868K |
|
4681
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$110M
| $1.28M | ﹤0.01% |
52,546
-554
| -1% | -$14.2K |
|
4682
Pulse Biosciences
PLSE
$3.18B
| $1.28M | ﹤0.01% |
264,100
+210,781
| +395% | +$1.73M |
|
|
EVOP
4683
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.28M | ﹤0.01% |
55,647
-36,214
| -39% | -$861K |
|
|
MCBC
4684
DELISTED
Macatawa Bank Corp
MCBC
| $1.28M | ﹤0.01% |
142,213
-40,662
| -22% | -$373K |
|
|
AKUS
4685
DELISTED
Akouos Inc
AKUS
| $1.28M | ﹤0.01% |
269,345
-34,127
| -11% | -$200K |
|
|
FGB
4686
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
| $1.28M | ﹤0.01% |
305,613
+141,972
| +87% | +$574K |
|
4687
Neurogene
NGNE
$723M
| $1.27M | ﹤0.01% |
33,906
+3,906
| +13% | +$228K |
|
4688
Commercial Vehicle Group
CVGI
$132M
| $1.27M | ﹤0.01% |
150,643
-16,963
| -10% | -$137K |
|
4689
Cytek Biosciences
CTKB
$610M
| $1.27M | ﹤0.01% |
117,887
+112,808
| +2,221% | +$1.52M |
|
|
JHI
4690
John Hancock Investors Trust
JHI
$118M
| $1.27M | ﹤0.01% |
75,662
+2,434
| +3% | +$41.2K |
|
|
CLVS
4691
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.27M | ﹤0.01% |
628,756
+264,213
| +72% | +$519K |
|
4692
Regis Corp
RGS
$69.3M
| $1.27M | ﹤0.01% |
29,894
-2,697
| -8% | -$94K |
|
|
CVE.WS
4693
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| $1.27M | ﹤0.01% |
109,578
-17,014
| -13% | -$172K |
|
|
NM
4694
DELISTED
Navios Maritime Holdings Inc.
NM
| $1.27M | ﹤0.01% |
348,776
+314,895
| +929% | +$1.12M |
|
4695
Old Second Bancorp
OSBC
$1.32B
| $1.26M | ﹤0.01% |
87,062
+8,882
| +11% | +$124K |
|
4696
Alico
ALCO
$297M
| $1.26M | ﹤0.01% |
33,639
+21,773
| +183% | +$758K |
|
4697
ADC Therapeutics
ADCT
$128M
| $1.26M | ﹤0.01% |
85,865
+15,022
| +21% | +$238K |
|
4698
First Community Bankshares
FCBC
$936M
| $1.26M | ﹤0.01% |
44,698
-2,045
| -4% | -$62.7K |
|
4699
Orion
OEC
$364M
| $1.26M | ﹤0.01% |
78,940
+29,968
| +61% | +$516K |
|
4700
Gold Royalty Corp
GROY
$725M
| $1.26M | ﹤0.01% |
304,892
-7,356
| -2% | -$31.2K |
|
Similar funds
Morgan Stanley's Q1 2022 Portfolio in Review
As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
- Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
- Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
- Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
- Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
- Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
- Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.